Skip to main content

Post-IPO Equity Therapeutics Companies

Explore 207 therapeutics startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
207
Total Funding
$2.7B
Avg Funding
$109.3M
Cities
18

Export 207 Post-IPO Equity Therapeutics Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Waltham, United States
$40.0M
raised

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Seattle, United States
$175.0M
raised

Perspective Therapeutics focuses on advancing cancer treatments employing radiation, radiopharmaceuticals, and imaging technology.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Menlo Park, United States
$11.2M
raised

Revelation Biosciences develops immunologic therapeutics and diagnostics designed to make the world a healthier place.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Richmond, United States
$115.0M
raised

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Chester, United Kingdom
$55.0M
raised

Canton Strategic Holdings drives institutional blockchain adoption via the Canton Network, digital assets, and market digitization.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 207 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Garden City, United States
$5.0M
raised

Beyond Air is a biotechnology company that focuses on the development of drugs for the treatment of lung infections.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Los Angeles, United States
$75.0M
raised

Kairos Pharma is a clinical-stage biopharmaceutical company focused on cancer immunotherapy and drug resistance.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Alpharetta, United States
$12.5M
raised

Dogwood Therapeutics is a clinical-stage biopharmaceutical company developing novel antiviral therapies for fibromyalgia and other diseases.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$50.0M
raised

Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Basel, Switzerland
$300.0M
raised

Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 207 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Carlton South, Australia
$2.9M
raised

Chimeric Therapeutics is a company developing ground-breaking CAR T cell therapies for solid tumors.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$20.1M
raised

IN8Bio is a biotechnology company focused on delivering a novel off-the-shelf product for the treatment of cancer.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Seattle, United States
$90.0M
raised

Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$30.0M
raised

CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$60.0M
raised

Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 207 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Diego, United States
$99.2M
raised

Contineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Menlo Park, United States
$18.0M
raised

Tivic Health is a commercial health tech company that develops bioelectronic medicine to alleviate symptoms of inflammatory conditions.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$602.0M
raised

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Tórtola, Spain
$1.3M
raised

CRISM Therapeutics is a pharmaceutical company that develops ChemoSeed to improve the clinical performance of cancer treatments.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$175.0M
raised

Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 207 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Boston, United States
$350.0M
raised

Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$75.0M
raised

Protara Therapeutics develops transformative therapies for people with cancer and rare diseases with limited treatment options.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Rockville, United States
$185.0M
raised

Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Miami Beach, United States
$60.0M
raised

Pasithea Therapeutics is a biotechnology company that seeks to solve clinical problems such as mental health.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Waltham, United States
$125.0M
raised

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 76 to 100 of 207 companies

Ready to Connect with Post-IPO Equity Therapeutics Startups?

Get verified founder emails, funding details, and company data for 207 post-ipo equity therapeutics companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

207 Therapeutics Post-IPO Equity Startups (November 2026) — Page 4 | VCBacked